INNOVATIVE STRATEGY IN THERAPY OF CARDIAC INSUFFICIENCY

INNOVATIVE STRATEGY IN THERAPY OF CARDIAC INSUFFICIENCY

The article is devoted to the innovative drug to treat chronic cardiac insufficiency – a combination of sakubitril neprilysin inhibitor and first type angiotension II receptor antagonist valsartan (sacubitril/valsartan). Study results are provided in which a combination of sacubitril/valsartan demon...

Full description

Bibliographic Details
Main Author: N. A. Jaiani
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-11-01
Series:Медицинский совет
Subjects:
cardiac insufficiency
rennin-angiotensin-aldosteron system
neprilysin
combination sacubitril/valsartan
Online Access:https://www.med-sovet.pro/jour/article/view/2019
Description
Summary:The article is devoted to the innovative drug to treat chronic cardiac insufficiency – a combination of sakubitril neprilysin inhibitor and first type angiotension II receptor antagonist valsartan (sacubitril/valsartan). Study results are provided in which a combination of sacubitril/valsartan demonstrated effectiveness in patients with arterial hypertension as well as with cardiac insufficiency. Advantages of a combination of sacubitril/valsartan as compared to other drugs affecting components of rennin-angiotension-aldosteron system from the point of view of safety and effectiveness in patients with cardiac insufficiency are demonstrated.
ISSN:2079-701X
2658-5790

Similar Items